HB 3338
Directs the Health Evidence Review Commission to evaluate gender-affirming treatment.
Jurisdiction
Oregon
Session
2025 Regular Session
Committee
Behavioral Health and Health Care
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill directs the Health Evidence Review Commission (HERC) to evaluate gender-affirming treatments in Oregon. The commission will assess the safety, effectiveness, and quality of evidence for various treatments, including puberty blockers, hormone therapy, and surgical procedures. The commission is required to produce a report by September 15, 2026, and make it publicly available.
Key provisions
- The Health Evidence Review Commission (HERC) will evaluate gender-affirming treatments.
- The evaluation will cover a range of treatments including puberty blockers, hormone replacement therapy, and surgical procedures.
- The commission must assess diagnostic criteria and assessment procedures.
- The commission must analyze the safety, efficacy, and quality of evidence for these treatments in children, adolescents, and adults.
- A report on the assessment must be submitted to the Legislative Assembly by September 15, 2026.
- The commission will make the report publicly available on the Oregon Health Authority website.
- The commission’s work is subject to its existing evidence-based report process and methodology.
Who is affected
- Healthcare providers
- Patients receiving gender-affirming care
- Oregon Health Authority
- The Legislative Assembly
- Consumers of healthcare
Notable changes
Sponsors
Official sponsors from legislative records.
Primary sponsors
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours